FULC Overview
Upcoming Projects (FULC)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (FULC)
-
Reviewing the recent decision by Pfizer to remove OXBRYTA (voxelotor) for sickle cell disease from the market.
Tickers: PFE, FULC
Executed On: Nov 12, 2024 at 04:45 PM EST -
A Second Look: Reviewing Avidity Biosciences Phase 1/2 FORTITUDE trial of AAOC- 1020 (del-brax) for FSHD
Tickers: RNA, FULC
Executed On: Aug 28, 2024 at 02:00 PM EDT -
Reviewing Avidity Biosciences Phase 1/2 FORTITUDE trial of AAOC- 1020 (del-brax) for FSHD
Tickers: RNA, FULC
Executed On: Jul 09, 2024 at 11:00 AM EDT -
Discussing the different therapeutic approaches from Fulcrum Therapeutics and Arrowhead Pharmaceuticals for the treatment of Facioscapulohumeral muscular dystrophy (FSHD)
Tickers: ARWR, RNA, FULC
Executed On: Jun 18, 2024 at 12:00 PM EDT -
A Third View: Discussing the Losmapimod data for Facioscapulohumeral muscular dystrophy (FSHD) from Fulcrum Therapeutics
Ticker: FULC
Executed On: May 30, 2023 at 06:30 PM EDT -
A second View: Discussing the Losmapimod data for Facioscapulohumeral muscular dystrophy (FSHD) from Fulcrum Therapeutics
Ticker: FULC
Executed On: Apr 13, 2023 at 10:45 AM EDT -
Discussing the Losmapimod data for Facioscapulohumeral muscular dystrophy (FSHD) from Fulcrum Therapeutics
Ticker: FULC
Executed On: Apr 12, 2023 at 04:30 PM EDT -
A Second Look: A Review of FTX-6058 in treating sickle cell disease following the update from EHA
Ticker: FULC
Executed On: Aug 19, 2022 at 04:15 PM EDT -
A Review of FTX-6058 in treating sickle cell disease following the update from EHA
Ticker: FULC
Executed On: Jul 11, 2022 at 05:00 PM EDT
Upcoming & Overdue Catalysts (FULC)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (FULC)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
